近視和老花眼治療市場：按疾病、治療方法和地區分類

預計到 2026 年，近視和老花眼治療市場規模將達到 310.5 億美元，到 2033 年將達到 549.7 億美元。預計 2026 年至 2033 年的複合年成長率將達到 8.5%。

老花眼和近視是描述眼部功能障礙的術語。近視是指難以看清遠處物體，而老花眼是指眼球水晶體難以在近距離和遠處物體之間進行聚焦。老花眼主要影響40至50歲的人。近視和老花眼的治療方法包括手術和藥物治療。此外，也可以透過配戴隱形眼鏡或框架眼鏡進行矯正。近視和老花眼的發生率在全球範圍內呈上升趨勢。近視是40歲以下人群視力障礙最常見的原因，而老花眼則是典型的與老齡化相關的近距離聚焦能力下降。瞇眼、眼睛疲勞和頭痛是近視或老花眼的徵兆。這些症狀可以透過配戴框架眼鏡、隱形眼鏡或屈光矯正手術來矯正或治療。此外，含有藥物成分的眼藥水正逐漸成為治療近視和老花眼的新方法。由於老花眼是老齡化相關的視力障礙，老年人口的成長是推動市場成長的主要因素之一。 40 歲以下視力障礙最常見的原因是近視，而老花眼是隨著老齡化成長，看近距離的能力正常下降。

市場動態

主要市場參與者推出新產品和療法，以及併購的增加，預計將推動全球近視和老花眼治療市場的成長。例如，2020年10月12日，專注於微劑量陣列印刷（MAP™）療法研發的臨床階段眼科生物製藥公司Eyenovia, Inc.及其全球眼科醫療保健業務部門博士倫健康公司（Bausch Health Companies Inc.）宣布，博士倫健康公司的一家關聯公司已獲得美國和加拿大獨家許可，負責開發和商業化該項在臨床實驗的微印技術。這種實驗性阿托品製劑將使用Eyenovia, Inc.的專利Optejet滴眼器技術進行給藥。

本研究的主要特點：

• 本研究確定了各個細分市場的潛在成長機會，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數分析了全球近視和老花眼治療市場的主要參與者：公司概況、產品系列、主要亮點、財務表現和策略。
• 本研究涵蓋的主要公司包括 ALCON Inc.、Bausch Health Companies Inc.、EssilorLuxottica (Essilor Ltd.)、Johnson & Johnson Vision、NIDEK CO. LTD.、Topcon Corporation、Zeimer Ophthalmic Systems AG 和 ZEISS International。
• 本報告提供的見解將有助於各公司的行銷負責人和經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份關於全球近視和老花眼治療市場的報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用分析全球近視和老花眼治療市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 近期產品發布
• 流行病學
• 併購和合作
• 監管趨勢
• 主要進展
• PEST分析

第4章 全球近視與老花眼治療市場：依疾病類型分類，2021-2033年

• 近視
• 老花眼

第5章 全球近視與老花眼治療市場：依治療類型分類，2021-2033年

• 處方鏡片
• 隱形眼鏡
• 外科手術
• 製藥
• 其他

第6章 全球近視與老花眼治療市場：按地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第7章 競爭情勢

• ALCON Inc.
• Bausch Health Companies Inc.
• EssilorLuxottica（Essilor Ltd.）
• Johnson & Johnson Vision
• NIDEK CO. LTD.
• Topcon Corporation
• Zeimer Ophthalmic Systems AG
• ZEISS International

第8章

• 調查方法
• 關於本公司

Myopia And Presbyopia Treatment Market is estimated to be valued at USD 31.05 Bn in 2026 and is expected to reach USD 54.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.

Presbyopia and myopia are terms used to describe eye dysfunction. Myopia makes it difficult to see objects in the distance, and presbyopia makes it difficult for the natural lens to shift its focus between near and far objects. Presbyopia affects people between the ages of 40 and 50. Surgery and medication are both options for treating myopia and presbyopia. Additionally, contact lenses or glasses can be used to treat these conditions. Myopia and presbyopia are becoming more common worldwide. The most frequent cause of vision impairment in people under the age of 40 is myopia (nearsightedness), whereas presbyopia is the typical age-related loss of near focusing ability. Squinting, eye strain, and headaches are signs of myopia and presbyopia. The conditions can be corrected or treated with eyeglasses, contact lenses, or refractive surgeries. Moreover, eye drops containing medication are also emerging treatments for myopia and presbyopia. Increasing geriatric population is one of the major factors driving the growth of the market, as presbyopia is an age-related visual impairment. Myopia (nearsighted) is the most common cause of impaired vision in people under the age of 40 while presbyopia is the normal loss of near focusing ability that occurs with age.

Market Dynamics

Increasing launches of new products,treatments, mergers, and acquisitions by key market players are expected to drive the global myopia and presbyopia treatment market growth. For instance, on October 12, 2020, Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company developing a pipeline of Microdose Array Print (MAPTM) therapeutics, and Bausch Health Companies Inc., its global eye health business, announced that an affiliate of Bausch Health Companies Inc. has acquired an exclusive license in the U.S. and Canada for the development and commercialization of an investigational microscopic print. This experimental atropine formulation is administered using Eyenovia, Inc. patented Optejet dispenser technology.

Key features of the study:

• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global myopia and presbyopia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global myopia and presbyopia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global myopia and presbyopia treatment market

Detailed Segmentation:

• Global Myopia And Presbyopia Treatment Market, By Disease Type (Revenue, USD Bn, 2021 - 2033)
• Myopia
• Presbyopia
• Global Myopia And Presbyopia Treatment Market, By Treatment Type (Revenue, USD Bn, 2021 - 2033)
• Prescription Lenses
• Contact Lenses
• Surgery
• Medication
• Others
• Global Myopia And Presbyopia Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa
• Company Profiles
• ALCON Inc.
• Bausch Health Companies Inc.
• EssilorLuxottica (Essilor Ltd.)
• Johnson & Johnson Vision
• NIDEK CO. LTD.
• Topcon Corporation
• Zeimer Ophthalmic Systems AG
• ZEISS International

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Disease Type
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaboration
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Myopia And Presbyopia Treatment Market, By Disease Type, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Myopia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Presbyopia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Myopia And Presbyopia Treatment Market, By Treatment Type, 2021-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Prescription Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Contact Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Myopia And Presbyopia Treatment Market, By Region, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2022-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• ALCON Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bausch Health Companies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• EssilorLuxottica (Essilor Ltd.)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson & Johnson Vision
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NIDEK CO. LTD.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Topcon Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zeimer Ophthalmic Systems AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ZEISS International
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

8. Section

• Research Methodology
• About Us